Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change

Shigeyoshi Honma, Manami Saika, Satoko Ohkubo, Hitoshi Kurose, Norimichi Nakahata

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Glial cells express thromboxane A2 receptor, but its physiological role remains unknown. The present study was performed to examine thromboxane A2 receptor-mediated morphological change in 1321N1 human astrocytoma cells. Thromboxane A2 receptor agonists U46619 and STA2 caused a rapid morphological change to spindle shape from stellate form of the cells pretreated with dibutyryl cyclic AMP, but neither carbachol nor histamine caused the change, suggesting that Gq pathway may not mainly contribute to the change. Rho kinase inhibitor Y-27632 inhibited U46619-induced morphological change, and U46619 increased the GTP-bound form of RhoA accompanied with actin stress fiber formation. These responses were reduced by expression of p115-RGS that inhibits G12/13 signaling pathway. U46619 also caused the phosphorylation of extracellular signal-regulated kinase (ERK) and [3H]thymidine incorporation mainly through G12/13-Rho pathway. These results suggest that stimulation of thromboxane A2 receptor causes the morphological change with proliferation mainly through G12/13 activation in glial cells.

Original languageEnglish
Pages (from-to)100-108
Number of pages9
JournalEuropean Journal of Pharmacology
Volume545
Issue number2-3
DOIs
Publication statusPublished - Sep 18 2006

Fingerprint

Prostaglandin H2 Receptors Thromboxane A2
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
Neuroglia
rho-Associated Kinases
Stress Fibers
Bucladesine
Extracellular Signal-Regulated MAP Kinases
Astrocytoma
Carbachol
Guanosine Triphosphate
Thymidine
Histamine
Actins
Phosphorylation

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. / Honma, Shigeyoshi; Saika, Manami; Ohkubo, Satoko; Kurose, Hitoshi; Nakahata, Norimichi.

In: European Journal of Pharmacology, Vol. 545, No. 2-3, 18.09.2006, p. 100-108.

Research output: Contribution to journalArticle

Honma, Shigeyoshi ; Saika, Manami ; Ohkubo, Satoko ; Kurose, Hitoshi ; Nakahata, Norimichi. / Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change. In: European Journal of Pharmacology. 2006 ; Vol. 545, No. 2-3. pp. 100-108.
@article{dba09aba5a18467f84d000446047cd83,
title = "Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change",
abstract = "Glial cells express thromboxane A2 receptor, but its physiological role remains unknown. The present study was performed to examine thromboxane A2 receptor-mediated morphological change in 1321N1 human astrocytoma cells. Thromboxane A2 receptor agonists U46619 and STA2 caused a rapid morphological change to spindle shape from stellate form of the cells pretreated with dibutyryl cyclic AMP, but neither carbachol nor histamine caused the change, suggesting that Gq pathway may not mainly contribute to the change. Rho kinase inhibitor Y-27632 inhibited U46619-induced morphological change, and U46619 increased the GTP-bound form of RhoA accompanied with actin stress fiber formation. These responses were reduced by expression of p115-RGS that inhibits G12/13 signaling pathway. U46619 also caused the phosphorylation of extracellular signal-regulated kinase (ERK) and [3H]thymidine incorporation mainly through G12/13-Rho pathway. These results suggest that stimulation of thromboxane A2 receptor causes the morphological change with proliferation mainly through G12/13 activation in glial cells.",
author = "Shigeyoshi Honma and Manami Saika and Satoko Ohkubo and Hitoshi Kurose and Norimichi Nakahata",
year = "2006",
month = "9",
day = "18",
doi = "10.1016/j.ejphar.2006.06.062",
language = "English",
volume = "545",
pages = "100--108",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "2-3",

}

TY - JOUR

T1 - Thromboxane A2 receptor-mediated G12/13-dependent glial morphological change

AU - Honma, Shigeyoshi

AU - Saika, Manami

AU - Ohkubo, Satoko

AU - Kurose, Hitoshi

AU - Nakahata, Norimichi

PY - 2006/9/18

Y1 - 2006/9/18

N2 - Glial cells express thromboxane A2 receptor, but its physiological role remains unknown. The present study was performed to examine thromboxane A2 receptor-mediated morphological change in 1321N1 human astrocytoma cells. Thromboxane A2 receptor agonists U46619 and STA2 caused a rapid morphological change to spindle shape from stellate form of the cells pretreated with dibutyryl cyclic AMP, but neither carbachol nor histamine caused the change, suggesting that Gq pathway may not mainly contribute to the change. Rho kinase inhibitor Y-27632 inhibited U46619-induced morphological change, and U46619 increased the GTP-bound form of RhoA accompanied with actin stress fiber formation. These responses were reduced by expression of p115-RGS that inhibits G12/13 signaling pathway. U46619 also caused the phosphorylation of extracellular signal-regulated kinase (ERK) and [3H]thymidine incorporation mainly through G12/13-Rho pathway. These results suggest that stimulation of thromboxane A2 receptor causes the morphological change with proliferation mainly through G12/13 activation in glial cells.

AB - Glial cells express thromboxane A2 receptor, but its physiological role remains unknown. The present study was performed to examine thromboxane A2 receptor-mediated morphological change in 1321N1 human astrocytoma cells. Thromboxane A2 receptor agonists U46619 and STA2 caused a rapid morphological change to spindle shape from stellate form of the cells pretreated with dibutyryl cyclic AMP, but neither carbachol nor histamine caused the change, suggesting that Gq pathway may not mainly contribute to the change. Rho kinase inhibitor Y-27632 inhibited U46619-induced morphological change, and U46619 increased the GTP-bound form of RhoA accompanied with actin stress fiber formation. These responses were reduced by expression of p115-RGS that inhibits G12/13 signaling pathway. U46619 also caused the phosphorylation of extracellular signal-regulated kinase (ERK) and [3H]thymidine incorporation mainly through G12/13-Rho pathway. These results suggest that stimulation of thromboxane A2 receptor causes the morphological change with proliferation mainly through G12/13 activation in glial cells.

UR - http://www.scopus.com/inward/record.url?scp=33747615722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747615722&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2006.06.062

DO - 10.1016/j.ejphar.2006.06.062

M3 - Article

VL - 545

SP - 100

EP - 108

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 2-3

ER -